Literature DB >> 27567214

[Baseline characteristics and clinical management of the first 3,000 patients enrolled in the IBERICAN study (Identification of the Spanish population at cardiovascular and renal risk)].

Sergio Cinza Sanjurjo1, Miguel Ángel Prieto Díaz2, José Luis Llisterri Caro3, Vicente Pallarés Carratalá4, Alfonso Barquilla García5, Luis Rodríguez Padial6, Ángel Díaz Rodríguez7, José Polo García8, Jesús Vergara Martín9, Rafael Vidal Pérez10, Gustavo Cristóbal Rodríguez Roca11.   

Abstract

OBJECTIVES: To determine the prevalence and incidence of cardiovascular risk factors in Spain, as well as cardiovascular events, in Spanish adult population attended in primary care.
METHODOLOGY: IBERICAN is a longitudinal, observational, multicenter study in which patients aged 18 to 85years attended in primary care health center in Spain are being included. The obtained cohort will be followed annually for at least 5years. The estimated final sample is 7,000 patients. The baseline characteristics of the second cut (n=3,042) are presented.
RESULTS: The mean age of the subjects included is 57.9±14.6 years, and 55.5% are women. 54.9% live in urban habitat, and 57.3% have primary education. 50.3% had dyslipidemia, 47.4% hypertension, 29.7% physical inactivity, 28.2% abdominal obesity and 19% diabetes mellitus. The degree of control of hypertension, dyslipidemia and type2 diabetes was 58.5%, 25.8% and 75.9%. 28.2% have criteria for metabolic syndrome. 15.6% of patients had previous cardiovascular disease. 7.8% have a history of coronary heart disease, a glomerular filtration rate <60ml/min (CKD-EPI) 8.4%, microalbuminuria 9.6%, atrial fibrillation 5.5%, stroke 4.6%, and heart failure 2.9%.
CONCLUSIONS: Although the population treated in primary care is relatively young, the high prevalence of risk factors, their poor control and the existence of previous cardiovascular disease will determine the impact on the prognosis of the cohort.
Copyright © 2016 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Atención primaria; Cardiovascular disease; Cardiovascular risk factors; Enfermedad cardiovascular; Factores de riesgo cardiovascular; Primary care

Mesh:

Year:  2016        PMID: 27567214     DOI: 10.1016/j.semerg.2016.07.006

Source DB:  PubMed          Journal:  Semergen        ISSN: 1138-3593


  5 in total

1.  Mild to moderate overweight in dogs: is there an impact on routine hematological and biochemical profiles, echocardiographic parameters and cardiac autonomic modulation?

Authors:  Aline Bomfim Vieira; Mariana Alvarez Restrepo; Danielle Auzenne; Kevin Molina; Meghan O'Sullivan; Marcus Vinicius Machado; Sarah Marie Cavanaugh
Journal:  Vet Res Commun       Date:  2022-01-12       Impact factor: 2.459

2.  Characterizing Diagnostic Inertia in Arterial Hypertension With a Gender Perspective in Primary Care.

Authors:  Vicente Pallares-Carratala; Concepcion Carratala-Munuera; Adriana Lopez-Pineda; Jose Antonio Quesada; Vicente Gil-Guillen; Domingo Orozco-Beltran; Jose L Alfonso-Sanchez; Jorge Navarro-Perez; Jose M Martin-Moreno
Journal:  Front Cardiovasc Med       Date:  2022-06-16

3.  Gender Differences in the Diagnosis of Dyslipidemia: ESCARVAL-GENERO.

Authors:  Cristina Soriano-Maldonado; Adriana Lopez-Pineda; Domingo Orozco-Beltran; Jose A Quesada; Jose L Alfonso-Sanchez; Vicente Pallarés-Carratalá; Jorge Navarro-Perez; Vicente F Gil-Guillen; Jose M Martin-Moreno; Concepción Carratala-Munuera
Journal:  Int J Environ Res Public Health       Date:  2021-11-25       Impact factor: 3.390

4.  Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study.

Authors:  Cristóbal Morales; Juan Francisco Merino-Torres; Paloma Moreno-Moreno; María Lainez; Iñigo Tejado; Alfredo Yoldi; Sonsoles Gutiérrez Medina; Alfonso Soto; Manuel A Botana; Virginia Bellido; Irene Caballero
Journal:  Drugs Context       Date:  2022-02-17

5. 

Authors:  Carlos Brotons Cuixart; José Juan Alemán Sánchez; José Ramón Banegas Banegas; Carlos Fondón León; José María Lobos-Bejarano; Enrique Martín Rioboó; Jorge Navarro Pérez; Domingo Orozco-Beltrán; Fernando Villar Álvarez
Journal:  Aten Primaria       Date:  2018-05       Impact factor: 1.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.